The opening price for Rite Aid Corporation (NYSE:RAD) was $0.802 and the volume amounted to 14794734 shares which compares with the average volume of 14171900 shares. The company stock experienced a -2.04% move to arrive at $0.8.Rite Aid Corporation (RAD) Analyst Opinion
Rite Aid Corporation is currently rated as hold by 6 stock analysts, with the company still having around 10.79% shares outstanding that can be sold short legally. The value of their shares went down by -19.01% last month. Over the course of a year, the stock has grown by 12.42%. Financial analysts are becoming more bearish than ever, with the 0 analysts who cover the activities of RAD advising investors to buy. Experts on Wall Street have set a price target of $1.02 for the stock. The decision was arrived after looking at their 27.5% gain from current levels. At the moment, Rite Aid Corporation (RAD) trading price is around -68.77% below its 52-week high.Rite Aid Corporation Earnings Surprise
Rite Aid Corporation (RAD) was unsuccessful in overcoming the expected -$0.01 as the stock recorded an earnings of -$1.00E-02 a piece during their last financial report presentation. Revenue, meanwhile, had a distance of -0.47% from the previous quarter, with the company recording $5.36 billion in revenue.Rite Aid Corporation (NYSE:RAD) Intraday View
The shares of Rite Aid Corporation (NYSE:RAD) have struggled and recovered 32.72% ever since it recorded its 52 week low. During the course of 5 days, the stock price volatility has remained at 7.53%, increasing the time frame to a month, the volatility recorded was 9.49%. The price of their shares has been successful in staying above its 20 days moving average, staying at a distance of 0.36% and while its 50 moving average is around -21.18%. A look at previous five trading sessionRAD stock had returned 6.43% and sank -43.73% when compared to its 200-day moving average that is $1.2954. Rite Aid Corporation (RAD) will look to overcome its -61.16% fall that it witnessed in the past one year.
As the normal trading session ended, the stock of CymaBay Therapeutics, Inc. (NASDAQ:CBAY), fetched in a $-0.03 retreat to $9.75. The session began with the stock price at $9.76, hitting a high of $9.78 before down again. For the week, analysts seem to be okay with their bullish with the consensus call staying at 0. CymaBay Therapeutics, Inc. gets 2 buy analyst recommendations while 0 recommend a hold and 0 rated it as a sell. The shares of the company tumbled -37.46% from its high $15.59, with their overall market value now roughly $548.34 million.CymaBay Therapeutics, Inc. (CBAY) Consensus Price Target
The mean recommendation of CBAY on Reuter’s scale remained unchanged from 1.78 to 1.78 within 30 days. This figure implies that the majority of analysts rate it as a buy. The price target for CymaBay Therapeutics, Inc. (NASDAQ:CBAY) is now around $22.33 a share, implying the stock has what it takes to grow by 129.03%. The recent trading session also indicated the stock needs to add 207.69% more meet analysts’ high consensus price target.CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Intraday Trading
The current trading volume of the company was 239159 shares during the last session. That compares with the recent average volume of 409140 shares. By the end of the regular trading session, the price volatility over a 1-week span was 7.41 while month stood 7.45%. The stock price of CBAY dropped to $9.51 during the day and at a certain time in 12 months it traded as low as $6.31. It has made a 54.52% recovery since its 52-week low point and has returned 23.89% year-to-date.